LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K982211
    Device Name
    PROFILE-II MODEL 600582
    Manufacturer
    MEDTOX DIAGNOSTICS, INC.
    Date Cleared
    1998-07-29

    (36 days)

    Product Code
    DKE,DIO,DJG,DKZ,LCM
    Regulation Number
    862.3870
    Type
    Traditional
    Panel
    Toxicology
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    PROFILE-II is a one-step immunochromatographic test for the rapid, qualitative detection of cannabinoids (THC), cocaine, opiates, amphetamines and phencyclidine (PCP) in human urine. The test detects the major metabolites of these drugs at the following cut-off concentrations:

    THC Tetrahydrocannabinol 50 ng/mL
    COC Cocaine (Benzoylecgonine) 300 ng/mL
    OPS Opiates (Codeine/Morphine) 300 ng/mL
    AMP Amphetamine 1000 ng/mL
    PCP Phencyclidine 25 ng/mL

    This product is intended for use under medical supervision in hospitals, physician offices, health clinics and drug treatment/counseling centers. It is not for over-the-counter sale.

    PROFILE-II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

    Device Description

    PROFILE-II is a one-step immunochromatographic test for the rapid, qualitative detection of cannabinoids (THC), cocaine, opiates, amphetamines and phencyclidine (PCP) in human urine.

    AI/ML Overview

    This document is a 510(k) clearance letter and an Indications for Use form for a rapid drug detection device called PROFILE-II. It does not contain the detailed study information regarding acceptance criteria and device performance that you requested.

    The document states the device's indications for use: "PROFILE-II is a one-step immunochromatographic test for the rapid, qualitative detection of cannabinoids (THC), cocaine, opiates, amphetamines and phencyclidine (PCP) in human urine." It also lists the cut-off concentrations for each drug.

    However, it does not provide:

    • A table of acceptance criteria and reported device performance.
    • Sample sizes used for test sets, data provenance, or details on prospective/retrospective studies.
    • Information on the number and qualifications of experts for ground truth establishment.
    • Adjudication methods.
    • Details on Multi-Reader Multi-Case (MRMC) comparative effectiveness studies or effect sizes.
    • Results of standalone (algorithm-only) performance.
    • The type of ground truth used (e.g., pathology, outcomes data, beyond the implied GC/MS confirmation).
    • Sample size for the training set.
    • How ground truth for the training set was established.

    This type of information is typically found in the full 510(k) submission, specifically in the performance data sections, which are not included in this letter. The letter is primarily an FDA clearance notification.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1